WallStreetZenWallStreetZen

NASDAQ: GNPX
Genprex Inc Stock Ownership - Who owns Genprex?

Insider buying vs selling

Have Genprex Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Mark Stanley BergerChief Medical Officer2024-02-181,319$4.40
$5.80kSell
Ryan M. ConferChief Financial Officer2024-02-181,126$4.40
$4.95kSell
John Rodney VarnerChairman President and CEO2024-02-182,642$4.40
$11.62kSell

1 of 1

GNPX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GNPX insiders and whales buy or sell their stock.

GNPX Shareholders

What type of owners hold Genprex Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Christy M. Nance157.36%3,006,298$6.64MInsider
Vanguard Group Inc95.61%1,826,600$4.04MInstitution
Jack A. Roth76.52%1,461,813$3.23MInsider
Cvi Holdings LLC32.36%618,256$1.37MInstitution
Geode Capital Management LLC25.80%492,842$1.09MInstitution
Blackrock Inc23.85%455,688$1.01MInstitution
Renaissance Technologies LLC18.82%359,500$794.50kInstitution
Catherine M. Vaczy13.87%265,000$585.65kInsider
Hermant Kumar10.47%200,000$442.00kInsider
Citadel Advisors LLC10.01%191,197$422.55kInstitution

1 of 3

GNPX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GNPX48.09%51.91%Net SellingNet Selling
TCON6.34%93.66%Net Selling
ENSC0.72%57.99%
SEEL3.20%96.80%Net BuyingNet Buying
LGVN14.25%85.75%Net BuyingNet Buying

Genprex Stock Ownership FAQ

Who owns Genprex?

Genprex (NASDAQ: GNPX) is owned by 263.72% institutional shareholders, 284.71% Genprex insiders, and 0.00% retail investors. Christy M. Nance is the largest individual Genprex shareholder, owning 3.01M shares representing 157.36% of the company. Christy M. Nance's Genprex shares are currently valued at $6.37M.

If you're new to stock investing, here's how to buy Genprex stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.